<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Brain Trust Speakers &#187; John Gardner Blog</title>
	<atom:link href="http://braintrustspeakers.com/category/speaker-blogs/john-gardner-blog/feed/" rel="self" type="application/rss+xml" />
	<link>http://braintrustspeakers.com</link>
	<description>Atlanta Professional Speakers Bureau</description>
	<lastBuildDate>Tue, 11 May 2010 18:22:54 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>The New Four P&#8217;s of Marketing &#8211; Pharmaceutical Executive</title>
		<link>http://braintrustspeakers.com/2009/12/29/the-new-four-ps-of-marketing-pharmaceutical-executive/</link>
		<comments>http://braintrustspeakers.com/2009/12/29/the-new-four-ps-of-marketing-pharmaceutical-executive/#comments</comments>
		<pubDate>Tue, 29 Dec 2009 14:17:53 +0000</pubDate>
		<dc:creator>Brain Trust</dc:creator>
				<category><![CDATA[In the Media]]></category>
		<category><![CDATA[John Gardner Blog]]></category>

		<guid isPermaLink="false">http://braintrustspeakers.com/2009/12/29/the-new-four-ps-of-marketing-pharmaceutical-executive/</guid>
		<description><![CDATA[
The New Four P&#8217;s of Marketing &#8211; Pharmaceutical Executive
Until relatively recently, pharmaceutical marketers “owned” the relationship with the Four P’s: product, placement, price, and promotion. It was straightforward: Develop a product, place it through a direct-to-physician distribution channel, set the price, and promote it via high-dollar physician events.
But these P’s have shifted their nexus. While [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://braintrustspeakers.com/wp-content/uploads/2009/12/pharmexeclogoImage1250007013808.gif"><img class="alignnone size-full wp-image-498" title="pharmexeclogoImage1250007013808" src="http://braintrustspeakers.com/wp-content/uploads/2009/12/pharmexeclogoImage1250007013808.gif" alt="" /></a></p>
<p><a href="http://pharmexec.findpharma.com/pharmexec/Web+Exclusives/The-New-Four-Ps-of-Marketing/ArticleStandard/Article/detail/647481?contextCategoryId=47505" target="_blank">The New Four P&#8217;s of Marketing &#8211; Pharmaceutical Executive</a></p>
<p>Until relatively recently, pharmaceutical marketers “owned” the relationship with the Four P’s: product, placement, price, and promotion. It was straightforward: Develop a product, place it through a direct-to-physician distribution channel, set the price, and promote it via high-dollar physician events.</p>
<p>But these P’s have shifted their nexus. While product development may still be in the pharmaceutical company’s hands, the other P’s are not. Regulatory constraints have taken placement out of the pharmaceutical marketer’s control. Price is under pressure from managed care and comparison shoppers. And promotion is no longer “directly” anywhere … it’s directly everywhere. Pharmaceutical marketers have lost control.</p>
<p><a href="http://pharmexec.findpharma.com/pharmexec/Web+Exclusives/The-New-Four-Ps-of-Marketing/ArticleStandard/Article/detail/647481?contextCategoryId=47505" target="_blank">Read more&#8230;</a></p>
<p>Posted using <a href="http://sharethis.com">ShareThis</a></p>

<!-- start wp-tags-to-technorati 1.01 -->

<!-- end wp-tags-to-technorati -->
]]></content:encoded>
			<wfw:commentRss>http://braintrustspeakers.com/2009/12/29/the-new-four-ps-of-marketing-pharmaceutical-executive/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

